Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Demography, baseline disease characteristics, and treatment history of psoriasis patients with self-reported psoriatic arthritis enrolled in the PSOLAR registry.

Kavanaugh A, Papp K, Gottlieb AB, de Jong EMGJ, Chakravarty SD, Kafka S, Langholff W, Farahi K, Srivastava B, Scher JU.

BMC Rheumatol. 2018 Sep 29;2:29. doi: 10.1186/s41927-018-0034-7. eCollection 2018.

2.

Inflammasome Signaling and Impaired Vascular Health in Psoriasis.

Garshick MS, Barrett TJ, Wechter T, Azarchi S, Scher JU, Neimann A, Katz S, Fuentes-Duculan J, Cannizzaro MV, Jelic S, Fisher EA, Krueger JG, Berger JS.

Arterioscler Thromb Vasc Biol. 2019 Apr;39(4):787-798. doi: 10.1161/ATVBAHA.118.312246.

PMID:
30760013
3.

Preventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition.

Scher JU, Ogdie A, Merola JF, Ritchlin C.

Nat Rev Rheumatol. 2019 Mar;15(3):153-166. doi: 10.1038/s41584-019-0175-0. Review.

PMID:
30742092
4.

Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.

Singh JA, Guyatt G, Ogdie A, Gladman DD, Deal C, Deodhar A, Dubreuil M, Dunham J, Husni ME, Kenny S, Kwan-Morley J, Lin J, Marchetta P, Mease PJ, Merola JF, Miner J, Ritchlin CT, Siaton B, Smith BJ, Van Voorhees AS, Jonsson AH, Shah AA, Sullivan N, Turgunbaev M, Coates LC, Gottlieb A, Magrey M, Nowell WB, Orbai AM, Reddy SM, Scher JU, Siegel E, Siegel M, Walsh JA, Turner AS, Reston J.

Arthritis Care Res (Hoboken). 2019 Jan;71(1):2-29. doi: 10.1002/acr.23789. Epub 2018 Nov 30.

PMID:
30499259
5.

Special Article: 2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis.

Singh JA, Guyatt G, Ogdie A, Gladman DD, Deal C, Deodhar A, Dubreuil M, Dunham J, Husni ME, Kenny S, Kwan-Morley J, Lin J, Marchetta P, Mease PJ, Merola JF, Miner J, Ritchlin CT, Siaton B, Smith BJ, Van Voorhees AS, Jonsson AH, Shah AA, Sullivan N, Turgunbaev M, Coates LC, Gottlieb A, Magrey M, Nowell WB, Orbai AM, Reddy SM, Scher JU, Siegel E, Siegel M, Walsh JA, Turner AS, Reston J.

Arthritis Rheumatol. 2019 Jan;71(1):5-32. doi: 10.1002/art.40726. Epub 2018 Nov 30.

PMID:
30499246
6.

Microbiota-Dependent Involvement of Th17 Cells in Murine Models of Inflammatory Arthritis.

Evans-Marin H, Rogier R, Koralov SB, Manasson J, Roeleveld D, van der Kraan PM, Scher JU, Koenders MI, Abdollahi-Roodsaz S.

Arthritis Rheumatol. 2018 Dec;70(12):1971-1983. doi: 10.1002/art.40657.

PMID:
29975009
7.

The Microbiome in Psoriasis and Psoriatic Arthritis: Joints.

Scher JU.

J Rheumatol Suppl. 2018 Jun;94:32-35. doi: 10.3899/jrheum.180134. Review.

PMID:
29858351
8.

Augmented Th17 Differentiation Leads to Cutaneous and Synovio-Entheseal Inflammation in a Novel Model of Psoriatic Arthritis.

Yang L, Fanok MH, Mediero-Munoz A, Fogli LK, Corciulo C, Abdollahi S, Cronstein BN, Scher JU, Koralov SB.

Arthritis Rheumatol. 2018 Jun;70(6):855-867. doi: 10.1002/art.40447. Epub 2018 Apr 18.

9.

The role of the gut microbiome in systemic inflammatory disease.

Clemente JC, Manasson J, Scher JU.

BMJ. 2018 Jan 8;360:j5145. doi: 10.1136/bmj.j5145. Review.

PMID:
29311119
10.

Alteration of the intestinal microbiome characterizes preclinical inflammatory arthritis in mice and its modulation attenuates established arthritis.

Rogier R, Evans-Marin H, Manasson J, van der Kraan PM, Walgreen B, Helsen MM, van den Bersselaar LA, van de Loo FA, van Lent PL, Abramson SB, van den Berg WB, Koenders MI, Scher JU, Abdollahi-Roodsaz S.

Sci Rep. 2017 Nov 15;7(1):15613. doi: 10.1038/s41598-017-15802-x.

11.

Potential risk factors for reactive arthritis and persistence of symptoms at 2 years: a case-control study with longitudinal follow-up.

Garcia Ferrer HR, Azan A, Iraheta I, Von Feldt J, Espinoza LR, Manasson J, Scher JU, Garcia Kutzbach A, Ogdie A.

Clin Rheumatol. 2018 Feb;37(2):415-422. doi: 10.1007/s10067-017-3911-3. Epub 2017 Nov 14.

12.

Human microbiome, infections, and rheumatic disease.

Caminer AC, Haberman R, Scher JU.

Clin Rheumatol. 2017 Dec;36(12):2645-2653. doi: 10.1007/s10067-017-3875-3. Epub 2017 Nov 3. Review.

PMID:
29101674
13.

Gut Microbiota Perturbations in Reactive Arthritis and Postinfectious Spondyloarthritis.

Manasson J, Shen N, Garcia Ferrer HR, Ubeda C, Iraheta I, Heguy A, Von Feldt JM, Espinoza LR, Garcia Kutzbach A, Segal LN, Ogdie A, Clemente JC, Scher JU.

Arthritis Rheumatol. 2018 Feb;70(2):242-254. doi: 10.1002/art.40359. Epub 2018 Jan 3.

14.

The 2018 landscape of RA, PsA, and SpA pathogenesis.

Scher JU.

Curr Opin Rheumatol. 2018 Jan;30(1):57-58. doi: 10.1097/BOR.0000000000000461. No abstract available.

PMID:
29035927
15.

Aberrant intestinal microbiota due to IL-1 receptor antagonist deficiency promotes IL-17- and TLR4-dependent arthritis.

Rogier R, Ederveen THA, Boekhorst J, Wopereis H, Scher JU, Manasson J, Frambach SJCM, Knol J, Garssen J, van der Kraan PM, Koenders MI, van den Berg WB, van Hijum SAFT, Abdollahi-Roodsaz S.

Microbiome. 2017 Jun 23;5(1):63. doi: 10.1186/s40168-017-0278-2.

16.

Psoriasis and Psoriatic Arthritis Clinics Multicenter Advancement Network Consortium (PPACMAN) Survey: Benefits and Challenges of Combined Rheumatology-dermatology Clinics.

Okhovat JP, Ogdie A, Reddy SM, Rosen CF, Scher JU, Merola JF.

J Rheumatol. 2017 May;44(5):693-694. doi: 10.3899/jrheum.170148.

PMID:
28461529
17.

The lung microbiota in early rheumatoid arthritis and autoimmunity.

Scher JU, Joshua V, Artacho A, Abdollahi-Roodsaz S, Öckinger J, Kullberg S, Sköld M, Eklund A, Grunewald J, Clemente JC, Ubeda C, Segal LN, Catrina AI.

Microbiome. 2016 Nov 17;4(1):60.

18.

Short- and long-term effects of oral vancomycin on the human intestinal microbiota.

Isaac S, Scher JU, Djukovic A, Jiménez N, Littman DR, Abramson SB, Pamer EG, Ubeda C.

J Antimicrob Chemother. 2017 Jan;72(1):128-136. Epub 2016 Oct 5.

19.

The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions.

Abdollahi-Roodsaz S, Abramson SB, Scher JU.

Nat Rev Rheumatol. 2016 Aug;12(8):446-55. doi: 10.1038/nrrheum.2016.68. Epub 2016 Jun 3. Review.

PMID:
27256713
20.

The microbiome in celiac disease: Beyond diet-genetic interactions.

Scher JU.

Cleve Clin J Med. 2016 Mar;83(3):228-30. doi: 10.3949/ccjm.83a.15123. No abstract available.

21.

Reply.

Scher JU, Abramson SB.

Arthritis Rheumatol. 2016 Jun;68(6):1569-70. doi: 10.1002/art.39644. No abstract available.

22.

Microbiome in Inflammatory Arthritis and Human Rheumatic Diseases.

Scher JU, Littman DR, Abramson SB.

Arthritis Rheumatol. 2016 Jan;68(1):35-45. doi: 10.1002/art.39259. Review. No abstract available.

23.

Reply: To PMID 25319745.

Scher JU, Reddy S, Ubeda C, Neimann A, Abramson SB.

Arthritis Rheumatol. 2015 May;67(8):2280-2. doi: 10.1002/art.39152. No abstract available.

24.

Erratum to: Analysis of Programmed Death-1 in Patients with Psoriatic Arthritis.

Peled M, Strazza M, Azoulay-Alfaguter I, Silverman GJ, Scher JU, Mor A.

Inflammation. 2015 Aug;38(4):1580. doi: 10.1007/s10753-015-0165-6. No abstract available.

PMID:
25847627
25.

Intestinal dysbiosis and potential consequences of microbiome-altering antibiotic use in the pathogenesis of human rheumatic disease.

Scher JU.

J Rheumatol. 2015 Mar;42(3):355-7. doi: 10.3899/jrheum.150036. No abstract available.

PMID:
25729039
26.

Analysis of Programmed Death-1 in Patients with Psoriatic Arthritis.

Peled M, Strazza M, Azoulay-Alfaguter I, Silverman GJ, Scher JU, Mor A.

Inflammation. 2015 Aug;38(4):1573-9. doi: 10.1007/s10753-015-0132-2. Erratum in: Inflammation. 2015 Aug;38(4):1580. Silverman, Gregg J [added]; Scher, Jose U [added].

PMID:
25663558
27.

Spondyloarthritis and the microbiome: new insights from an ancient hypothesis.

Manasson J, Scher JU.

Curr Rheumatol Rep. 2015 Feb;17(2):10. doi: 10.1007/s11926-014-0487-7. Review.

PMID:
25663180
28.

Gene, environment, microbiome and mucosal immune tolerance in rheumatoid arthritis.

Catrina AI, Deane KD, Scher JU.

Rheumatology (Oxford). 2016 Mar;55(3):391-402. doi: 10.1093/rheumatology/keu469. Epub 2014 Dec 23. Review.

29.

Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism.

Zanin-Zhorov A, Weiss JM, Nyuydzefe MS, Chen W, Scher JU, Mo R, Depoil D, Rao N, Liu B, Wei J, Lucas S, Koslow M, Roche M, Schueller O, Weiss S, Poyurovsky MV, Tonra J, Hippen KL, Dustin ML, Blazar BR, Liu CJ, Waksal SD.

Proc Natl Acad Sci U S A. 2014 Nov 25;111(47):16814-9. doi: 10.1073/pnas.1414189111. Epub 2014 Nov 10.

30.

Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease.

Scher JU, Ubeda C, Artacho A, Attur M, Isaac S, Reddy SM, Marmon S, Neimann A, Brusca S, Patel T, Manasson J, Pamer EG, Littman DR, Abramson SB.

Arthritis Rheumatol. 2015 Jan;67(1):128-39. doi: 10.1002/art.38892.

31.

Biomarkers in psoriatic arthritis: recent progress.

Chandran V, Scher JU.

Curr Rheumatol Rep. 2014 Nov;16(11):453. doi: 10.1007/s11926-014-0453-4. Review.

PMID:
25218735
32.

Periodontal disease and subgingival microbiota as contributors for rheumatoid arthritis pathogenesis: modifiable risk factors?

Scher JU, Bretz WA, Abramson SB.

Curr Opin Rheumatol. 2014 Jul;26(4):424-9. doi: 10.1097/BOR.0000000000000076. Review.

33.

Microbiome and mucosal inflammation as extra-articular triggers for rheumatoid arthritis and autoimmunity.

Brusca SB, Abramson SB, Scher JU.

Curr Opin Rheumatol. 2014 Jan;26(1):101-7. doi: 10.1097/BOR.0000000000000008. Review.

35.

Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis.

Scher JU, Sczesnak A, Longman RS, Segata N, Ubeda C, Bielski C, Rostron T, Cerundolo V, Pamer EG, Abramson SB, Huttenhower C, Littman DR.

Elife. 2013 Nov 5;2:e01202. doi: 10.7554/eLife.01202.

36.

Monotherapy in rheumatoid arthritis.

Scher JU.

Bull Hosp Jt Dis (2013). 2013;71(3):204-7. Review.

37.

Association of medication beliefs and self-efficacy with adherence in urban Hispanic and African-American rheumatoid arthritis patients.

Spruill TM, Ogedegbe G, Harrold LR, Potter J, Scher JU, Rosenthal PB, Greenberg JD.

Ann Rheum Dis. 2014 Jan;73(1):317-8. doi: 10.1136/annrheumdis-2013-203560. Epub 2013 Jul 31. No abstract available.

38.

B-cell therapies for rheumatoid arthritis.

Scher JU.

Bull NYU Hosp Jt Dis. 2012;70(3):200-3. Review.

39.

Periodontal disease and the oral microbiota in new-onset rheumatoid arthritis.

Scher JU, Ubeda C, Equinda M, Khanin R, Buischi Y, Viale A, Lipuma L, Attur M, Pillinger MH, Weissmann G, Littman DR, Pamer EG, Bretz WA, Abramson SB.

Arthritis Rheum. 2012 Oct;64(10):3083-94. doi: 10.1002/art.34539.

40.

Re: Clinical periodontal and microbiologic parameters in patients with rheumatoid arthritis.

Rosenstein ED, Scher JU, Bretz WA, Weissmann G.

J Periodontol. 2011 Nov;82(11):1521-3; author reply 1523. doi: 10.1902/jop.2011.110393. No abstract available.

PMID:
22043938
41.

Rheumatoid arthritis and periodontitis: a possible link via "citation".

Rosenstein ED, Scher JU, Bretz WA, Weissmann G.

Anaerobe. 2012 Feb;18(1):162. doi: 10.1016/j.anaerobe.2011.10.003. Epub 2011 Oct 17. No abstract available.

PMID:
22019980
42.

The microbiome and rheumatoid arthritis.

Scher JU, Abramson SB.

Nat Rev Rheumatol. 2011 Aug 23;7(10):569-78. doi: 10.1038/nrrheum.2011.121. Review.

43.

The anti-inflammatory effects of prostaglandins.

Scher JU, Pillinger MH.

J Investig Med. 2009 Aug;57(6):703-8. doi: 10.2310/JIM.0b013e31819aaa76. Review.

PMID:
19240648
44.

Helicobacter pylori stimulates gastric epithelial cell MMP-1 secretion via CagA-dependent and -independent ERK activation.

Pillinger MH, Marjanovic N, Kim SY, Lee YC, Scher JU, Roper J, Abeles AM, Izmirly PI, Axelrod M, Pillinger MY, Tolani S, Dinsell V, Abramson SB, Blaser MJ.

J Biol Chem. 2007 Jun 29;282(26):18722-31. Epub 2007 May 2.

45.

Nitric oxide synthases and osteoarthritis.

Scher JU, Pillinger MH, Abramson SB.

Curr Rheumatol Rep. 2007 Apr;9(1):9-15. Review.

PMID:
17437661
46.

Matrix metalloproteinase secretion by gastric epithelial cells is regulated by E prostaglandins and MAPKs.

Pillinger MH, Marjanovic N, Kim SY, Scher JU, Izmirly P, Tolani S, Dinsell V, Lee YC, Blaser MJ, Abramson SB.

J Biol Chem. 2005 Mar 18;280(11):9973-9. Epub 2005 Jan 7.

47.

15d-PGJ2: the anti-inflammatory prostaglandin?

Scher JU, Pillinger MH.

Clin Immunol. 2005 Feb;114(2):100-9. Review.

PMID:
15639643

Supplemental Content

Loading ...
Support Center